About
Technology
Therapeutics
Partnering
Careers
Newsroom
Contact
Twitter
Linkedin
Contact Us

Newsroom

BigHat on Genetic Engineering & Biotechnology News

Read more

📢 We are pleased to announce that our pioneering work on next-generation therapeutics was featured in Genetic Engineering & Biotechnology News.

Explore the profile that highlights BigHat Biosciences at the forefront of creating better biologics faster!

đź“– Read the full article

‍

Posted:
10/26/2023
Read Time:
14
mins
Words by:

Newsroom

11.4.2024
Lonza’s Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC
Press
8.13.2024
BigHat featured on Genetic Engineering & Biotechnology News
Announcements
8.5.2024
BigHat named to the 2024’s Fierce Biotech 15
Announcements
6.27.2024
BigHat’s Cofounder and CSO, Peyton Greenside, Joins the Timmerman Traverse for Sickle Forward
Announcements
4.24.2024
BigHat Biosciences Enters into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
Press
2.27.2024
BigHat’s CIO on Software Engineering Daily podcast
Announcements
12.5.2023
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
Press
10.26.2023
BigHat on Genetic Engineering & Biotechnology News
Press
8.2.2023
BigHat’s CSO on Biocom CA’s Lifelines Podcast
Announcements
6.8.2023
BigHat’s CSO presents at Antibody Engineering and Therapeutics Conference Europe 2023
Presentations
6.1.2023
BigHat Appoints John Corbin, PhD as Chief Development Officer
Announcements
12.21.2022
BigHat Year in Review 2022
Announcements
11.29.2022
BigHat Biosciences Announces Research Collaboration with Merck
Announcements
9.29.2022
BigHat Biosciences validates best-in-class security posture with spotless SOC2 audit
Announcements
7.20.2022
BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies
Announcements
7.20.2022
BigHat raises $75M Series B
Announcements
6.23.2022
BigHat’s CSO and VP Engineering speaking at AWS Summit San Francisco
Announcements
5.11.2022
BigHat Biosciences Appoints Rob Chess, Serial Entrepreneur, to its Board of Directors
Announcements
3.28.2022
BigHat Biosciences Completes Its Acquisition of Frugi Biotechnology
Announcements
3.8.2022
Luminaries Rob Chess, Mark Pegram and Michael Jewett join BigHat’s Advisory Board
Announcements
3.1.2022
BigHat in Pharma’s Almanac Q1 2022 Issue
Announcements
2.23.2022
BigHat’s CEO and CSO on BIOS Builders podcast
Announcements
1.13.2022
BigHat’s CSO presents at Antibody Engineering and Therapeutics Conference
Announcements
1.11.2022
BigHat Biosciences Completes First Stage of Research Collaboration with Amgen
Announcements
12.22.2021
BigHat Holiday Memo 2021
Announcements
10.30.2021
BigHat’s New Facility
Announcements
10.27.2021
BigHat Wins “2021 Therapeutics Innovation of the Year” from BioTech Breakthrough
Announcements
10.12.2021
BigHat selected as the winner at the UCSF Health Awards
Announcements
8.18.2021
BigHat’s CSO on Moneyball Medicine podcast
Announcements
8.17.2021
BigHat featured on Pinpoint Case Study
Announcements
8.12.2021
BigHat’s VP of Engineering featured on AWS Healthcare and Life Sciences CTO Fellowship
Announcements
8.3.2021
BigHat named to Business Insider’s top 24 Biotech startups by leading VCs
Press
7.29.2021
Healthcare finance expert Amol Pawar joins BigHat Advisory team
Announcements
7.28.2021
BigHat publishes research on active learning applied to proteins at the 2021 ICML Workshop on Computational Biology
Announcements
6.29.2021
BigHat CSO and Co-Founder Peyton Greenside recognized as one of Silicon Valley Business Journal’s Women Of Influence for 2021
Announcements
6.17.2021
BigHat Featured on AWS DevOps Blog
Announcements
4.8.2021
BigHat presents at AI for Drug Discovery 2021 conference
Announcements
3.22.2021
BigHat founders discuss AI for Biologics with a16z on Clubhouse
Announcements
3.16.2021
BigHat at WuXi Healthcare Forum 2021
Announcements
3.1.2021
BigHat CSO on the future of machine learning and computational biology at Stanford Computer Science AI Salon
Announcements
2.10.2021
BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments
Announcements
2.10.2021
BigHat raises $19M Series A
Announcements
12.14.2020
Antibody developer Steve Doberstein joins BigHat advisory team
Announcements
11.18.2020
Peyton Greenside, BigHat CSO, speaks about machine-guided biological design
Announcements
11.1.2020
BigHat Biosciences earns Phase I award from NIST to show power of AI-driven platform
Announcements
9.15.2020
BigHat awarded 2020 Golden Ticket from Amgen and MBC Biolabs
Announcements
8.12.2020
BigHat founder discusses COVID-19's impact on early-stage startups
Announcements
7.18.2020
BigHat founder presents active learning innovations at ICML 2020
Announcements
6.9.2020
BigHat founder speaks at the annual European Society for Human Genetics (ESHG) 2020 meeting
Announcements
4.30.2020
BigHat founder talks leading interdisciplinary teams with Stanford Accel Scholars
Announcements
12.4.2019
BigHat founder at the Cell Free Systems conference
Announcements
11.11.2019
BigHat founder moderates Deep Life salon
Announcements
10.30.2019
BigHat founder speaks at Open Data Science conference
Announcements
10.22.2019
BigHat closes oversubscribed seed round
Announcements
Contact
1900 Alameda de las Pulgas
Suite 400
San Mateo, CA 94403
Navigation
About
Technology
Therapeutics
Partnering
Careers
Newsroom
Social
Twitter
Linkedin
© BigHat Bio 2023